Dudediligence.

BioAtla, Inc

BCABNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeSep 29 →InsidersNo open-market buys or sales.→HoldersMillennium 4.2%Lido 1.0%Stonepine 1.0%→Financing →PeersClosest companies: WVE, PDSB, JSPR→

From the filings

Figures

Net income
$87.8Mlast 12 months
Operating cash flow
−$37.2Mlast 12 months
Cash and equivalents
$1.5Mat the last balance sheet
Shares outstanding
1.7M shareson issue
Every year and quarter →